Vaso Corporation Announces Fourth Extension of Exclusive Sales Representation Agreement with GE Healthcare

Author's Avatar
Oct 29, 2021

PLAINVIEW, NY / ACCESSWIRE / October 29, 2021 / Vaso Corporation ("Vaso") (OTCMKTS:VASO) today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE Healthcare ("GEHC"), the healthcare business unit of General Electric Company (NYSE:GE), originally signed on May 19, 2010.